CureVac’s German Owner Rejects US Coronavirus Vaccine Grab
Made In Germany For the World Is Hopp’s Vision
Dietmar Hopp, 80% shareholder of German mRNA company CureVac, has rejected the possibility that the company would sign an exclusive deal with the US for its investigational coronavirus vaccine.
